eVTOL investors got a clean reminder on June 22 that price action is still rewarding the names with the most credible milestone path and the deepest trading liquidity. JOBY closed at $10.00, up 6.50% on 44,916,500 shares, ACHR rose 3.92% to $5.57 on 40,987,200 shares, and EH slipped 0.42% to $7.03 on 1,796,600 shares, while the U.S. 10-year Treasury yield held at 4.45% and fed funds sat at 3.63%.
For today’s detailed market data, see Joby Daily, Archer Daily, and EHang Daily.
Is the market pricing Joby’s 2028 bull case too early, before production and revenue can really inflect?
I think the answer is yes, and my lean is cautious to skeptical on timing. 24/7 Wall St framed the upside case around a possible 2028 share price of $20, but that same source also kept 2026 revenue guidance at just $105 million to $115 million. That is an important mismatch. A company guiding barely above $100 million in annual revenue is still proving commercialization, yet the stock is already being debated as though a mature scaling story is close to locked in.
The production math in today’s source set makes the gap harder to ignore. AOL’s Joby summary said the company is producing roughly two aircraft per month while the long-run operating pitch still reaches for 500 aircraft per year. Even without layering on outside assumptions, that means today’s installed pace is about 24 aircraft annually against a much later target that is more than twenty times larger. The way I see it, investors are not valuing the business that exists now; they are valuing a later system that still depends on FAA type certification, Dubai commercialization, U.S. service launch, and Dayton manufacturing scale all landing in sequence.
The market is still willing to finance that hope because liquidity remains strong. JOBY reclaimed $10.00 on 44.9 million shares, which was more volume than Archer and vastly more than EHang. Its RSI14 at 33.33 also says the stock is not extended in a euphoric sense. That matters because this does not look like a blowoff move driven by pure mania. It looks more like investors wanting to own the name before the next visible regulatory or production milestone arrives. Higher rates also make that choice more demanding: with the 10-year yield still at 4.45%, future cash flows should be discounted more heavily, so a stock that still wins attention in that setting is clearly being judged on milestone credibility rather than present income.
Still, the bridge from narrative to operating proof is not short. Today’s raw coverage also included the ongoing Joby-Archer trade-secret dispute through Crypto Briefing, which is a reminder that execution risk here is not only technical or regulatory. Legal distraction, management bandwidth, and reputational pressure can all matter when a company is trying to prove certification discipline and manufacturing readiness at the same time. The stock can hold up if investors believe these are temporary sidewinds, but it becomes harder to justify premium pricing if every unresolved issue stacks on top of the same commercialization window.
My read is constructive on Joby as a long-duration contender, but cautious on paying too much today for a 2028 outcome that still requires several hard gates to clear first. If monthly production begins rising meaningfully above the current two-aircraft pace and revenue starts moving beyond the $105 million to $115 million band, the market can earn the right to underwrite the bull case earlier. Until then, the current setup looks like a stock pricing the destination faster than the business is proving the route.
Why are institutions still giving Archer a bigger portfolio weight than Joby despite weak revenue and heavy losses?
Because Archer still looks like the cleaner optionality trade inside thematic portfolios, even if the current financial statements are weak. Today’s file set showed ARKX holding ACHR at 3.10% and 6,322,296 shares versus JOBY at 2.53% and 2,941,197 shares. That is not a trivial difference. It suggests at least one visible innovation-focused holder still prefers Archer’s setup as the better asymmetric bet.
The contradiction is obvious on the income statement. Archer’s Q1 revenue was only $1.6 million and its net loss reached $217.7 million, so the fundamentals do not justify enthusiasm on their own. Yet AOL’s Archer coverage still laid out a bullish 12-month target of $11.51 because the market is focused on certification proximity, international airline partnerships, Saudi PIF-related expectations, defense-linked program exposure, and LA28 commercialization ambition. The same article also noted Goldman Sachs had shifted to Hold, which matters because it shows even cautious sell-side framing has not fully broken the optionality narrative. My view is that investors are tolerating ugly near-term numbers because they still think the next rerating trigger is milestone-based rather than revenue-based.
That helps explain why Archer can carry heavier ETF weight than Joby even on a day when Joby’s tape looked stronger. JOBY gained 6.50% versus Archer’s 3.92%, and Joby traded slightly more shares. But Joby also carries a more mature debate around valuation, insider-selling concerns, production ramp credibility, and whether the 2028 case is already partly priced in. Archer, by contrast, is still being bought more like a call option on certification and partner execution. Today’s file set explicitly kept Archer tied to Stage 4 progress, with the most recent confirmation dated 2026-06-17, and that kind of milestone framing is exactly what thematic investors tend to overweight.
There is also a practical portfolio-construction reason this spread can persist. A fund manager looking across the basket may decide that Joby already has the more fully recognized brand in the public market, while Archer still offers more room for sentiment expansion if one or two milestones break right. That does not make Archer safer. It makes Archer more convex. In a sector where the winners can rerate sharply on certification or launch headlines, convexity often gets more capital than clean present-day fundamentals.
The same lawsuit coverage affecting Joby also keeps Archer in the conversation, while defense-adjacent comparisons like The Motley Fool’s Archer-vs-Kraken piece reinforce the idea that Archer has more than one narrative lane for capital to latch onto. My directional lean here is constructive but speculative: institutions appear to prefer Archer not because the business is cleaner today, but because the upside from certification, partnerships, government-linked programs, and a still-open analyst debate feels less fully priced than Joby’s longer-publicized bull case.
If this volume gap keeps going, does EHang become dead money rather than an oversold rebound candidate?
For now, yes, and my lean is bearish near term. EH closed at $7.03 with RSI14 at 29.83, which on paper can look like classic oversold territory. But oversold only matters when capital is ready to respond, and today’s tape did not show that response. EHang traded just 1,796,600 shares versus 44,916,500 for Joby and 40,987,200 for Archer. In a speculative sector, that is not a minor gap. It is a sign that market attention has migrated elsewhere.
The absence of fresh catalyst flow makes the liquidity problem worse. Today’s EHang daily package said there was no company-specific official press release, no FAA update, no SEC filing, and no in-window article driving the stock during the last 23 hours. That leaves EH trading mostly on technical posture rather than narrative expansion. Meanwhile, Joby still has an active valuation-versus-execution debate, and Archer still has certification and institutional-positioning debate. Even negative legal headlines can keep money engaged if they keep a ticker relevant. EHang had none of that today.
The chart posture is not strong enough to force a rebound on its own. EH is below SMA5 at $7.08 and well below SMA20 at $8.50, so the stock is losing both the short-term and medium-term trend tests. A sub-30 RSI can mark a bounce zone, but without turnover it often becomes a value trap where the stock screens cheap and stays ignored. My read is that liquidity matters more than the oversold signal right now. Until buyers show up in size, technical “cheapness” is not doing much work.
There is also a comparative problem. Investors do not buy eVTOL names in isolation; they compare where momentum, headline flow, and milestone visibility are clustering. On this score, EHang is clearly behind the peer group today. Joby had the $10 reclaim and manufacturing debate, Archer had the ETF-weight and certification debate, and EHang had neither a fresh corporate disclosure nor a new external catalyst strong enough to reset the conversation. When that pattern persists, capital tends to stay parked in the names that already command attention.
What would change the story is straightforward. First, EHang needs a real volume pickup, not just a small green day. Second, it needs to reclaim SMA5 and hold above it, because that would at least show short-term buyers are returning. Third, it needs a fresh company-specific catalyst strong enough to pull it back into the peer conversation. Until then, I think EH is closer to dead money than to a high-conviction rebound setup, because the market is currently rewarding names with active milestones and heavy participation rather than names that are merely statistically oversold.
What to Watch Tomorrow
- First, watch whether Joby can hold the $10.00 level while volume stays elevated, because losing that reclaim would weaken the argument that investors are underwriting the next certification or production milestone.
- Second, watch whether Archer gets any fresh certification, analyst, partner, or government-program headline that validates the 3.10% ARKX weight and keeps the optionality trade alive.
- Third, watch whether EHang can push turnover meaningfully above 1.8 million shares and recover at least its $7.08 SMA5 line, because without that trigger the oversold case remains weak.
This is not financial advice. Do your own research.
Follow @futurewatchlog for daily eVTOL coverage.
Previous insight: eVTOL Daily Insight – 2026-06-21